Drug intelligence / Profile preview

Fe3O4-PEG

Development stage: Unknown
Modality: Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems

Overview

Fe3O4-PEG nanoparticles are a type of nanocarrier system used for targeted drug delivery. They consist of iron oxide (Fe3O4) nanoparticles coated with polyethylene glycol (PEG). This coating enhances their biocompatibility, stability in biological fluids, and ability to evade the immune system, allowing for prolonged circulation and efficient delivery of therapeutic agents to target sites under the guidance of an external magnetic field[1][2].

Beyond the preview

Go deeper on Fe3O4-PEG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fe3O4-PEG.

Explore the full profile